longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CLDI

CLDI
1.0800.00%( 0.000 )

LongbridgeAI

Pre-market hot trades in US stocks: Hims & Hers Health up 3.21% in pre-market

Price Alert
Jul 9, 2025 at 01:16 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Hims & Hers Health pre-market up 3.21%; Calidi Biotherapeutics pre-market up 175.46%; Evoke Pharma pre-market up 167.67%; SU pre-market up 126.87%

Pre-market Hot Trades in US Stocks

Top Gainers in Pre-market US Stocks

Calidi Biotherapeutics is up 175.46% in pre-market trading. According to recent key news:

  1. On July 8, Calidi Biotherapeutics announced the publication of an article on NetworkNewsWire, which increased market attention to its brand, resulting in a significant stock price increase of 175.46%.

SU is up 126.87% in pre-market trading. Based on recent important news:

  1. On June 24, Hong Kong-listed China Tianrui Group Cement resumed trading, initially rising over 60%, now up 40%. This news may boost market sentiment, impacting SU's stock price increase.

  2. On June 23, a mid-term strategy meeting for the securities industry was held, with good expectations for year-on-year net profit growth, enhancing market confidence.

  3. On June 21, during JP Morgan's Investor Day event, market sentiment fluctuated, and investors' alertness to market risks decreased

Login to unlock425characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 9, 2026 at 09:04 PMNovo Nordisk's weight loss drug advertisement was deemed "false or misleading" by the FDA, and the stock price hit a new…
  • Feb 6, 2026 at 09:33 PMFDA warns of "swift action," HIMS weight loss drug generic plan thwarted, stock price falls nearly 6%
  • Feb 5, 2026 at 11:09 PMNovo Nordisk plummeted 8%, as the new weight loss pill faced "knockoffs" right after its launch, with telemedicine compa…

Related Stocks

Hims & Hers Health

Hims & Hers Health

USHIMS

-1.02%

Calidi Biotherapeutics

Calidi Biotherapeutics

USCLDI

0.00%

Evoke Pharma

Evoke Pharma

USEVOK

0.00%